ANI Pharmaceuticals

Highly Engaged Employees

ANI Pharmaceuticals, founded in 2001, is a diversified biopharmaceutical company specializing in the development, manufacturing, and marketing of high-quality branded and generic prescription pharmaceutical products. The company focuses on delivering sustainable growth through its Purified Cortrophin Gel franchise and by enhancing its generics business with advanced development capabilities. Operating within the healthcare sector, ANI Pharmaceuticals leverages robust North American manufacturing infrastructure to serve patients effectively.

The organization maintains a workforce of 500-1,000 employees and operates with a strategic focus on innovation in established brands. Learn about ANI Pharmaceuticals's global headquarters for geographic details regarding their primary facility in Baudette, Minnesota. By integrating specialty pharmaceutical services and maintaining rigorous quality standards, the company continues to expand its footprint in the competitive biopharmaceutical landscape, ensuring reliable supply chains for critical medical treatments.

With a reported annual revenue of $978.4M, the company demonstrates significant market presence as a publicly traded entity under the ticker NASDAQ: ANIP. Explore financial highlights to review detailed metrics and funding history, including recent debt financing from major institutional investors. Meet ANI Pharmaceuticals's team to learn about their leadership and organizational structure. Through its commitment to niche drug development and contract manufacturing, ANI Pharmaceuticals remains a key player in the North American healthcare market, consistently delivering value to stakeholders and patients alike.